Immediate Impact
52 standout
Citing Papers
Allogeneic CD33-directed CAR-NKT cells for the treatment of bone marrow-resident myeloid malignancies
2025 Standout
Hepatocellular carcinoma: signaling pathways, targeted therapy, and immunotherapy
2024 Standout
Works of Lai-Fong Poon being referenced
ABT-869, a multi-targeted tyrosine kinase inhibitor, in combination with rapamycin is effective for subcutaneous hepatocellular carcinoma xenograft
2008
In vivo activity of ABT-869, a multi-target kinase inhibitor, against acute myeloid leukemia with wild-type FLT3 receptor
2008
Author Peers
| Author | Last Decade | Papers | Cites | ||||
|---|---|---|---|---|---|---|---|
| Lai-Fong Poon | 192 | 105 | 51 | 65 | 8 | 306 | |
| Vladimir Janković | 207 | 95 | 24 | 78 | 8 | 319 | |
| Alice Can Ran Qin | 214 | 39 | 42 | 79 | 7 | 312 | |
| Riccardo Ronzoni | 178 | 37 | 31 | 69 | 13 | 345 | |
| Zhenbiao Xia | 275 | 123 | 11 | 51 | 9 | 367 | |
| Chris Riffkin | 211 | 65 | 10 | 80 | 10 | 323 | |
| José Javier | 119 | 81 | 15 | 67 | 8 | 276 | |
| Guilhem Couderc | 197 | 141 | 9 | 140 | 9 | 364 | |
| Maximillian Hafer | 133 | 72 | 25 | 97 | 9 | 334 | |
| Sylvia Katz | 232 | 35 | 20 | 67 | 10 | 352 | |
| Rositsa Koleva | 207 | 24 | 13 | 65 | 7 | 304 |
All Works
Login with ORCID to disown or claim papers
Loading papers...